摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-ethyl-4-hydroxy-3-(p-methylbenzoyl)-4-(p-methylphenyl) piperidine

中文名称
——
中文别名
——
英文名称
1-ethyl-4-hydroxy-3-(p-methylbenzoyl)-4-(p-methylphenyl) piperidine
英文别名
Methanone, [1-ethyl-4-hydroxy-4-(4-methylphenyl)-3-piperidinyl](4-methylphenyl)-;[1-ethyl-4-hydroxy-4-(4-methylphenyl)piperidin-3-yl]-(4-methylphenyl)methanone
1-ethyl-4-hydroxy-3-(p-methylbenzoyl)-4-(p-methylphenyl) piperidine化学式
CAS
——
化学式
C22H27NO2
mdl
——
分子量
337.462
InChiKey
ADTJYHHPIOXMGN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    40.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    1-ethyl-4-hydroxy-3-(p-methylbenzoyl)-4-(p-methylphenyl) piperidine碘甲烷乙醚 为溶剂, 反应 5.0h, 以75%的产率得到1-ethyl-4-hydroxy-1-methyl-3-(p-methylbenzoyl)-4-(p-methylphenyl) piperidinium iodide
    参考文献:
    名称:
    Gul, Halise Inci; Gul, Mustafa; Erciyas, Ercin, Arzneimittel-Forschung/Drug Research, 2002, vol. 52, # 8, p. 628 - 635
    摘要:
    DOI:
  • 作为产物:
    描述:
    聚合甲醛乙胺对甲基苯乙酮 反应 8.5h, 以36%的产率得到1-ethyl-4-hydroxy-3-(p-methylbenzoyl)-4-(p-methylphenyl) piperidine
    参考文献:
    名称:
    Gul, Halise Inci; Gul, Mustafa; Erciyas, Ercin, Arzneimittel-Forschung/Drug Research, 2002, vol. 52, # 8, p. 628 - 635
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • EP1242080A4
    申请人:——
    公开号:EP1242080A4
    公开(公告)日:2003-01-22
  • DOPAMINE TRANSPORTER INHIBITORS AND THEIR USE
    申请人:GEORGETOWN UNIVERSITY
    公开号:EP1242080A1
    公开(公告)日:2002-09-25
  • [EN] DOPAMINE TRANSPORTER INHIBITORS AND THEIR USE<br/>[FR] INHIBITEURS DU TRANSPORTEUR DE DOPAMINE ET LEUR UTILISATION
    申请人:UNIV GEORGETOWN
    公开号:WO2001022964A1
    公开(公告)日:2001-04-05
    The present invention provides a novel class of compounds. The compounds are inhibitors of dopamine transporter and therefore are useful in the treatment of disorders related to dopamine transporter activity. One aspect of the present invention provides a class of compounds of formula (I): wherein R1 is an alkyl, aryl, alkyl-aryl, aromatic ring containing one or more hetero atoms; R2 is an alkyl, aryl, aromatic ring containing one or more hetero atoms, ketone, hydroxyl, alcohol, aldehyde, ester, acid, amide group, or (1) or (2), wherein R' is a phenyl ring optionally substituted with one or more halogens or one or more saturated or unsaturated alkyl (C1-5) group, or aromatic ring with one or more hereto atoms optionally substituted with one or more halogens or one or more saturated or unsaturated alkyl (C1-5) group; R3 is F, C1, Br, I, OH, OR', or OC=OR', wherein R' is an alkyl, aryl, aromatic ring containing one or more hetero atoms, or a -O- bond with R2 when R2 is hydroxyl or alcohol; R4 is an alkyl, aryl, alkyl-aryl; aromatic ring containing one or more hetero atoms, hydroxyl, alcohol, aldehyde, ester, acid, amide group.
查看更多